KGbio
Company

KGbio

Biotechnology Id 33 employees
Employees
33
Contacts
1
Emails
1

KGbio Overview

Headquarters
Id
Industry
Biotechnology
Employees
33
Funding
55.0M

About KGbio

KGbio is a clinical-stage biotechnology company focused on bringing biologics medical innovation to markets outside the US/Canada, Western Europe and China. The business model revolves around in-licensing novel biologics and select biosimilars in oncology and high-specialty therapeutic areas (typically pre-IND or early clinical stage), with the objective to out-license them in target geographies after finishing clinical development as well as regulatory and reimbursement approvals. Platforms of interest currently include Fc-fusion proteins, antibodies, bispecifics, ADCs, cell therapies and therapeutic vaccines. The company is backed by Asian pharma companies Kalbe (market cap US$5.5 billion) and Genexine (market cap US$1.3 billion) and US private equity giant General Atlantic (AUM US$ 78 billion).

KGbio Contact Details

People in AeroLeads
4
With contact data
1
Email contacts
1
25.0% coverage

KGbio Org Chart

Sample employees and titles
Name Title Contact
Steven Amadeus IT Core & Operation Head of Sbu
View
Vonny Willianti Business Development & Licensing Senior
View
Sven Tang M.d. Chief Medical Officer at Kgbio
Email
Artati Md, Mm Doctor
View

Employees by Management Level

Executive 1 profile
VP / Head 1 profile
Senior / Lead 1 profile
Individual contributor 1 profile

Compare Similar Companies to KGbio